Medical institutions worldwide can now leverage Gattaca Genomics' unparalleled expertise in genetic research and diagnostics, complemented by the embedded payment and financial services provided by Ibanera’s advanced technologies.
Key Points:
- Medical institutions worldwide can now leverage Gattaca Genomics' unparalleled expertise in genetic research and diagnostics, complemented by the embedded payment and financial services provided by Ibanera’s advanced technologies.
- This alliance underscores a shared commitment to innovation, excellence, and client-centric services, uniting Gattaca’s genetic innovation with Ibanera’s digital banking prowess, ensuring smoother financial processes for healthcare innovations.
- Michael Carbonara, CEO of both Gattaca Genomics and Ibanera, expresses his enthusiasm for the partnership, affirming, "Our journey at Ibanera to provide Banking-as-a-Service has reached new heights through our collaboration with Gattaca Genomics.
- With both innovation and family values as our guiding principles, we are thrilled to support Gattaca’s pioneering strides in leveraging AI for family planning by facilitating seamless banking and payment processes."
Florida, March 21, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics , a leader in reproductive health and genetic testing services, is proud to announce the appointment of Dr. Gary L. Harton, PhD, as a consultant and Principal Scientific Advisor.
Key Points:
- Florida, March 21, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics , a leader in reproductive health and genetic testing services, is proud to announce the appointment of Dr. Gary L. Harton, PhD, as a consultant and Principal Scientific Advisor.
- Gary Harton, with a PhD from the University of Kent and a distinguished career spanning several leading genetics and reproductive health organizations, has joined Gattaca Genomics to enhance the company's scientific and research endeavours.
- ", says Dr. Harton
"We are incredibly fortunate to have Dr. Gary Harton join our team as a consultant and Principal Scientific Advisor.
- “The entire Gattaca Genomics team looks forward to working with Dr. Harton and benefiting from his expertise and leadership.”
Aneuploidy,
RBM,
Human Reproduction (journal),
Reproductive medicine,
Genetics,
REACH,
IVF,
Associate,
Society,
Abstract,
Genetic testing,
Knowledge,
Genomics,
Management Florida, March 06, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a leading name in genetic services, appoints Dr. Tyl Taylor as its new Director of Genetics Services.
Key Points:
- Florida, March 06, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a leading name in genetic services, appoints Dr. Tyl Taylor as its new Director of Genetics Services.
- Dr. Taylor brings a wealth of experience and expertise in the field, making him a valuable addition to the Gattaca team.
- In his role as the Director of Genetics Services at Gattaca, Dr. Taylor is poised to lead the team towards new heights in genetic research and reproductive technologies.
- We are confident that under his guidance, Gattaca will continue to drive advancements in genetic services," said Michael Carbonara, CEO of Gattaca Genetics.
Retrieved on:
Tuesday, February 27, 2024
Fort Lauderdale, Florida, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics proudly appoints renowned scientist, Dr. Eva Schenkman, as the Director of Embryology Services.
Key Points:
- Fort Lauderdale, Florida, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics proudly appoints renowned scientist, Dr. Eva Schenkman, as the Director of Embryology Services.
- Dr. Schenkman's appointment as Director of Embryology Services signifies Gattaca Genomics' commitment to attracting top-tier talent in the field.
- In her capacity as Director of Embryology Services, Dr. Schenkman will leverage her extensive experience in IVF laboratory management, andrology, and embryology to lead Gattaca Genomics in pioneering advancements in reproductive health.
- Michael Carbonara, CEO of Gattaca Genomics says, "Dr. Eva Schenkman's appointment is a testament to Gattaca Genomics' commitment to excellence.
Retrieved on:
Tuesday, February 6, 2024
Whole genome sequencing,
Aneuploidy,
Genomics,
AI,
Patient,
Fertility,
Genetic testing,
Artificial intelligence,
Anomaly,
LLM,
Senior counsel,
DSM-IV codes,
Deep learning,
Genetic counseling,
Risk,
Algorithm,
Health,
PGT,
Medical device By integrating advanced artificial intelligence (AI) technologies the company aspires to enhance the success rates of fertility procedures.
Key Points:
- By integrating advanced artificial intelligence (AI) technologies the company aspires to enhance the success rates of fertility procedures.
- Utilizing sophisticated hyperparameter turning and deep learning, Gattaca Genomics develops precise genetic analysis, identifying anomalies and patterns with unparalleled accuracy.
- Harnessing the power of large language models (LLM), Gattaca Genomics transforms the landscape of genetic counseling in assisted reproductive processes.
- Gattaca Genomics integrates expert, independent, board-certified genetic counseling services seamlessly into its AI-driven genetic testing process.
Retrieved on:
Thursday, January 18, 2024
Entrepreneurship,
Family,
Whole genome sequencing,
Patient,
Regenerative medicine,
Heart,
IVF,
Knowledge,
Reproductive medicine,
Genetics,
WGS,
Genetic testing,
Risk,
Quality of life,
Genomics,
Genetic counseling,
Genome,
DSM-IV codes,
PGT,
Chromosome,
Management Fort Lauderdale, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a pioneering next generation company innovating solutions for reproductive health, is set to revolutionize family planning with its advanced genetic testing services.
Key Points:
- Fort Lauderdale, FL, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Gattaca Genomics, a pioneering next generation company innovating solutions for reproductive health, is set to revolutionize family planning with its advanced genetic testing services.
- Specializing in Preimplantation Genetic Testing (PGT), Gattaca Genomics employs state-of-the-art techniques to enhance pregnancy success rates, identify chromosomal abnormalities, and reduce the risk of genetic disorders.
- Whole Genome Sequencing (WGS): Gattaca Genomics introduces a breakthrough in genetic testing with Whole Genome Sequencing, offering a comprehensive analysis of an individual's entire genome.
- Gattaca Genomics invites prospective parents, healthcare providers, and clinicians to explore the possibilities that genetic testing can offer.
